IL6 and cancer: Several studies have shown the Treg involvement in colorectal tumorigenesis, e.g. IL-6 and IL-10 both enhanced tumorigenesis in colitis-associated cancer models [58, 59], whereas blockade of IL17A inhibited tumor growth [28].